ANIXA BIOSCIENCES, INC. Interest Payable, Current
ANIXA BIOSCIENCES, INC. (ANIX) had Interest Payable, Current of $20.67 thousand as of 2017-07-31, per its 10-Q filed 2017-09-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2017-09-08
- 2017-07-31: Interest Payable, Current $20.67K.
- 2017-04-30: Interest Payable, Current $30.00K.
- 2012-10-31: Interest Payable, Current $8.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2017-07-31 | $20.67K 10-Q · filed 2017-09-08 |
| 2017-04-30 | $30.00K 10-Q · filed 2017-05-26 |
| 2012-10-31 | $8.00K 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |